公共咨询

医疗器械登记 到 ANVISA

按号码、产品、持有公司或CNPJ搜索,数据是ANVISA在公开数据中发布的,每天都会到达这里。

5,848 记录

产品持有公司班级有效性
SOLUCAO EURO-COLLINS - Para Perfusao de rins em transplante10004100066FRESENIUS KABI BRASIL LTDAIV17/08/2036
PROTESE VASCULAR UNI-GRAFT10008530004LABORATORIOS B. BRAUN S/AIV24/02/2034
NEURO-PATCH - MEMBRANAS MICROPOROSAS PARA SUBSTITUIÇÃO DA DURAMATER10008530068LABORATORIOS B. BRAUN S/AIV07/06/2036
FILTRO DE VEIA CAVA10008530412LABORATORIOS B. BRAUN S/AIV27/12/2026
Lab Rapid Syphilis10009010358LABTEST DIAGNOSTICA S/AIV10/08/2030
Lab Rapid HCV10009010359LABTEST DIAGNOSTICA S/AIV10/08/2030
Lab Rapid HBsAg10009010363LABTEST DIAGNOSTICA S/AIV16/11/2030
Lab Rapid HIV Tri Line 1/210009010365LABTEST DIAGNOSTICA S/AIV21/12/2030
Anti-HBe Reagent Kit10009010462LABTEST DIAGNOSTICA S/AIV21/10/2034
Anti-HBc Reagent Kit10009010463LABTEST DIAGNOSTICA S/AIV21/10/2034
HBsAg Reagent Kit10009010467LABTEST DIAGNOSTICA S/AIV21/10/2034
HBeAg Reagent Kit10009010468LABTEST DIAGNOSTICA S/AIV21/10/2034
Anti-HCV Reagent Kit10009010469LABTEST DIAGNOSTICA S/AIV21/10/2034
HIV Ag/Ab Combo Reagent Kit10009010470LABTEST DIAGNOSTICA S/AIV21/10/2034
Anti-HBs Reagent Kit10009010471LABTEST DIAGNOSTICA S/AIV21/10/2034
Syphilis TP Reagent Kit10009010476LABTEST DIAGNOSTICA S/AIV21/10/2034
Toxo IgM Reagent Kit10009010478LABTEST DIAGNOSTICA S/AIV21/10/2034
HBsAg Qualitative Reagent Kit10009010480LABTEST DIAGNOSTICA S/AIV21/10/2034
Toxo IgG Reagent Kit10009010481LABTEST DIAGNOSTICA S/AIV21/10/2034
CMV IgG Reagent Kit10009010498LABTEST DIAGNOSTICA S/AIV11/08/2035
Anti-HBc IgM Reagent Kit10009010504LABTEST DIAGNOSTICA S/AIV29/09/2035
CMV IgM Reagent Kit10009010505LABTEST DIAGNOSTICA S/AIV13/10/2035
Família Anti-HCV Cartridge10009010507LABTEST DIAGNOSTICA S/AIV11/05/2036
Família HIV Ag/Ab Combo Cartridge10009010509LABTEST DIAGNOSTICA S/AIV06/07/2036
Access HBs Ag Confirmatory10033120984BECKMAN COULTER DO BRASIL COMÉRCIO E IMPORTAÇÃO DE PRODUTOS DE LABORATÓRIO LTDAIV30/04/2028

来源: ANVISA 开放数据,健康产品档案. 基础带来注册的有效性,而不是记录情况:注册可能在期限之前被取消,而不会在这里出现。 咨询门户 ANVISA.

接下来的步骤

您的产品需要在巴西注册

HSC在 ANVISA 中进行医疗器械登记,从风险类框架到过程跟踪。

联系专家